Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Accenture
Chinese Patent Office
Colorcon
Harvard Business School
Mallinckrodt
Cipla
US Department of Justice

Generated: April 22, 2018

DrugPatentWatch Database Preview

FUNDUSCEIN-25 Drug Profile

« Back to Dashboard

Which patents cover Funduscein-25, and when can generic versions of Funduscein-25 launch?

Funduscein-25 is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in FUNDUSCEIN-25 is fluorescein sodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the fluorescein sodium profile page.
Drug patent expirations by year for FUNDUSCEIN-25
Medical Subject Heading (MeSH) Categories for FUNDUSCEIN-25
Synonyms for FUNDUSCEIN-25
(3H)Xanthen-3-one, 10-deshydro-6-hydroxy-10-[2-carboxyphen-1-yl]-
121511-05-5
1flr
1n0s
2-(3-hydroxy-6-keto-xanthen-9-yl)benzoic acid
2-(3-hydroxy-6-oxo-6H-xanthen-9-yl)benzoic acid
2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoesaure
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid #
2-(6-hydroxy-3-oxoxanthen-9-yl)benzoic acid
2-(6-oxido-3-oxo-3H-xanthen-9-yl)benzoate
208117-76-4
3',6'-Dihydroxy-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one
3'',6''-dihydroxyspiro[1,3-dihydroisobenzofuran-1,9''-(9''H-xanthene)]-3-one
31949-37-8
321H075
3266-99-7
34517-88-9
3H-Xanthen-3-one, 6-hydroxy-10-[2-carboxyphenyl]-
41935-48-2
518-45-6
574737-69-2
893427-14-0
93X55PE38X
AC1L1FT8
AC1L1VKD
AC1MVAYI
Aizen uranine
AKOS000503167
AKOS024364966
AN-23513
ARONIS014456
AS-17142
BB_NC-0386
BBL002034
BDBM50143424
C Yellow No. 8
C.I. 45350
C.I.45350:1
C20H10O5.2Na
Calcocid uranine B4315
CBDivE_002901
CHEMBL1628233
CHEMBL177756
cid_3383
CTK1G3923
D &
D02024
dipotassium 2-(3-oxido-6-oxoxanthen-9-yl)benzoate
disodium 2-(3-oxido-6-oxo-xanthen-9-yl)benzoate
disodium 2-(3-oxido-6-oxoxanthen-9-yl)benzoate
disodium 2-(6-oxido-3-oxo-3H-xanthen-9-yl)benzoate
Disodium-6-Hydroxy-3-oxo-9-Xanthene-o-Benzoate
DR002105
F0096
Floures (TN)
flourescein
Fluor-I-strip A.T.
Fluorescein 2Na
Fluorescein disodium salt 100g
Fluorescein sodium (JP17/USP)
Fluorescein sodium salt
fluorescein, sodium salt
Fluorescein, soluble
Fluoresein sodium
FT-0626450
Ful-Glo
KS-000044VW
MCULE-1559500470
MCULE-8810198732
MFCD00066735
MOLI001004
MolPort-001-783-925
MolPort-003-929-261
NJDNXYGOVLYJHP-UHFFFAOYSA-L
PL006388
PL043171
SBB001359
SCHEMBL107875
SCHEMBL264060
Soluble fluorescein
ST009474
STK391288
T217
T7547
TG2-210
UNII-93X55PE38X
Uranine K hydrate
YKGGGCXBWXHKIZ-UHFFFAOYSA-N
Z1262246141
ZINC3872582

US Patents and Regulatory Information for FUNDUSCEIN-25

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis FUNDUSCEIN-25 fluorescein sodium INJECTABLE;INJECTION 017869-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Moodys
US Department of Justice
Covington
Boehringer Ingelheim
Fuji
Teva
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.